for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

DarioHealth Corp

DRIO.OQ

Latest Trade

15.01USD

Change

-0.23(-1.51%)

Volume

103,449

Today's Range

13.76

 - 

15.21

52 Week Range

10.06

 - 

31.82

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest Developments

DarioHealth Q3 Revenue Rises 176% To $5.6 Mln

Nov 15 (Reuters) - DarioHealth Corp <DRIO.O>::DARIOHEALTH REPORTS THIRD QUARTER 2021 RESULTS AND OPERATIONAL HIGHLIGHTS.Q3 REVENUE ROSE 176 PERCENT TO $5.6 MILLION.CASH AND CASH EQUIVALENTS TOTALED $51.3 MILLION ON SEPT 30, 2021.QTRLY LOSS PER SHARE $1.18.Q3 EARNINGS PER SHARE VIEW $-0.94, REVENUE VIEW $5.8 MILLION -- REFINITIV IBES DATA.

Dariohealth Corp Announced Launch Of Dario Move

Oct 18 (Reuters) - DarioHealth Corp <DRIO.O>::DARIOHEALTH CORP - ANNOUNCED LAUNCH OF DARIO MOVE.

DarioHealth Corp Enters Into Agreement To Provide Its Suite Of Digital Therapeutics To A Northeast Regional Employer

Sept 9 (Reuters) - DarioHealth Corp <DRIO.O>::DARIOHEALTH CORP - ENTERED INTO AN AGREEMENT TO PROVIDE ITS SUITE OF DIGITAL THERAPEUTICS TO A NORTHEAST REGIONAL EMPLOYER.DARIOHEALTH CORP - CONTRACT IS EXPECTED TO CONTRIBUTE REVENUE BEGINNING IN Q1 OF 2022.

DarioHealth Reports Q2 Loss Per Share Of $0.99

Aug 16 (Reuters) - DarioHealth Corp <DRIO.O>::DARIOHEALTH REPORTS STRONG SECOND QUARTER 2021 RESULTS AND OPERATIONAL HIGHLIGHTS.TOTAL Q2 REVENUE OF $5.3 MILLION INCREASED 194% YEAR-OVER-YEAR.ENDED Q2 2021 WITH CASH AND CASH EQUIVALENTS OF $63.9 MILLION.QTRLY LOSS PER SHARE $0.99.Q2 REVENUE VIEW $5.1 MILLION -- REFINITIV IBES DATA.

DarioHealth Reports Qtrly Net Loss Per Share $0.92

May 17 (Reuters) - DarioHealth Corp <DRIO.O>::DARIOHEALTH REPORTS FIRST QUARTER 2021 RESULTS AND OPERATIONAL HIGHLIGHTS.DARIOHEALTH CORP - REVENUES FOR Q1 ENDED MARCH 31, 2021 WERE $3.6 MILLION, A 73% SEQUENTIAL INCREASE FROM Q4 ENDED DECEMBER 31, 2020.DARIOHEALTH CORP - QTRLY NET LOSS PER SHARE $0.92.DARIOHEALTH CORP - OBSERVED Q1 2021 REVENUE OF ABOUT $4.7 MILLION, ASSUMING ACQUISITION OF UPRIGHT TECHNOLOGIES CLOSED ON JANUARY 1, 2021.

DarioHealth Reports 18.1% Increase In Quarterly Non-GAAP Billings

March 9 (Reuters) - DarioHealth Corp <DRIO.O>::DARIOHEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2020 RESULTS AND OPERATIONAL HIGHLIGHTS.DARIOHEALTH CORP - REVENUES FOR Q4 ENDED DECEMBER 31, 2020 WERE $2.08 MILLION, A 1.9% SEQUENTIAL INCREASE FROM Q3 ENDED SEPTEMBER 30, 2020.DARIOHEALTH CORP - REVENUES FOR Q4 ENDED DECEMBER 31, 2020 WERE $2.08 MILLION, A 1.9% SEQUENTIAL INCREASE FROM Q3 ENDED SEPTEMBER 30, 2020.DARIOHEALTH - NON-GAAP BILLINGS FOR QUARTER ENDED DEC 31, 2020 WERE $2.02 MILLION, AN 18.1% INCREASE FROM $1.71 MILLION REPORTED IN QUARTER ENDED DEC 31, 2019.

Dariohealth Announces Acquisition Of Leading Digital Musculoskeletal Co Upright Technologies And $70 Million Financing

Jan 27 (Reuters) - DarioHealth Corp <DRIO.O>::DARIOHEALTH ANNOUNCES ACQUISITION OF LEADING DIGITAL MUSCULOSKELETAL COMPANY UPRIGHT TECHNOLOGIES AND $70 MILLION FINANCING.DARIOHEALTH CORP - DEAL FOR $31 MILLION.DARIOHEALTH CORP - AGREED TO ACQUIRE UPRIGHT FOR $31 MILLION WITH $29.5 PAID IN STOCK AND $1.5 MILLION IN CASH.DARIOHEALTH CORP - UNAUDITED REVENUES FOR 2020 ARE ESTIMATED TO REACH APPROXIMATELY $7.6 MILLION, INCLUDING ESTIMATED REVENUES OF $2.12 MILLION IN Q4 OF 2020.DARIOHEALTH - EXECUTED SECURITIES PURCHASE AGREEMENTS FOR SALE OF 3.28 MILLION SHARES OF ITS COMMON STOCK AT $21.35 PER SHARE.

Dariohealth Reports Third Quarter 2020 Results

Nov 12 (Reuters) - DarioHealth Corp <DRIO.O>::DARIOHEALTH REPORTS THIRD QUARTER 2020 RESULTS.Q3 LOSS PER SHARE $0.71.Q3 REVENUE ROSE 9.3 PERCENT TO $2.04 MILLION.

Dariohealth Says Selling Stockholders May Offer Up To 3.83 Million Shares Of Common Stock

Sept 8 (Reuters) - DarioHealth Corp <DRIO.O>::DARIOHEALTH CORP SAYS SELLING STOCKHOLDERS MAY OFFER UP TO 3.83 MILLION SHARES OF COMMON STOCK - SEC FILING.

DarioHealth Says Q2 Revenue Rose 8.2% To $1.79 Million

Aug 12 (Reuters) - DarioHealth Corp <DRIO.O>::DARIOHEALTH REPORTS SECOND QUARTER 2020 RESULTS.Q2 REVENUE ROSE 8.2 PERCENT TO $1.79 MILLION.Q2 LOSS PER SHARE $0.68.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up